type
interferon
ifn
play
crucial
role
innat
immun
avantgard
viral
infect
virtual
virus
develop
mean
counteract
induct
signal
antivir
action
ifn
circuit
differ
virusencod
ifn
antagonist
distinct
virus
describ
indic
virus
interfer
multipl
stage
ifn
respons
although
everi
viral
ifn
antagonist
uniqu
right
four
main
mechan
employ
circumv
innat
immun
respons
gener
inhibit
cellular
gene
express
ii
sequestr
molecul
ifn
circuit
iii
proteolyt
cleavag
iv
proteasom
degrad
key
compon
ifn
system
increas
understand
differ
viral
ifn
antagonist
function
translat
gener
virus
mutant
ifn
antagonist
potenti
live
vaccin
candid
moreov
ifn
antagonist
attract
target
inhibit
smallmolecul
compound
innat
immun
system
form
first
line
defens
invad
microorgan
virus
dampen
initi
viru
replic
ensur
surviv
host
special
adapt
respons
develop
type
interferon
ifn
secret
key
cytokin
innat
immun
axi
protect
uninfect
cell
stimul
leukocyt
resid
interfac
innat
adapt
immun
macrophag
dendrit
cell
dc
cell
prod
adapt
immun
system
mount
full
special
respons
invad
microb
abil
outrun
innat
immun
adapt
immun
respons
mount
crucial
surviv
virtual
mammalian
virus
regardless
genom
type
complex
rel
simpl
virus
rna
virus
picornavirida
famili
well
dna
virus
larg
genom
member
poxvirida
famili
shown
inhibit
ifn
system
review
cover
latest
insight
virusencod
antagonist
sidetrack
ifn
machineri
knowledg
current
use
gener
second
gener
live
vaccin
antivir
compound
viral
nucleic
acid
protein
recogn
tolllik
receptor
plasma
membran
endosom
predominantli
antigen
present
cell
apc
moreov
cell
express
cytoplasm
sensor
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
gene
recogn
viral
rna
cytoplasm
microbi
bform
dna
recogn
dnasensor
dai
cellular
rna
polymeras
iii
convert
triphosph
contain
rna
recogn
rigi
upon
activ
rigi
engag
mitochondri
antivir
signal
adapt
mav
turn
mav
activ
two
kinas
complex
ultim
phosphoryl
activ
two
key
transcript
factor
ifnb
induct
nuclear
factor
kb
nfkb
ifnregulatori
factor
first
kinas
complex
consist
tnf
receptor
associ
factor
traf
famili
member
associ
nfkb
activ
tank
tankbind
kinas
inhibitor
kb
kinas
ikb
e
ikk
second
complex
phosphoryl
ikb
therebi
activ
nfkb
consist
receptor
interact
protein
nfkb
essenti
modul
nemo
tgfb
activ
kinas
ikka
ikkb
upon
activ
nfkb
transloc
nucleu
drive
ifnb
transcript
figur
cytoplasm
domain
kinas
phosphoryl
key
transcript
factor
signal
transduc
activ
transcript
stat
togeth
form
ifnstimul
gene
factor
complex
activ
transcript
complex
transloc
nucleu
drive
express
isg
date
public
report
identif
andor
character
differ
virusencod
ifn
antagonist
distinct
virus
suppl
tabl
past
four
year
number
report
describ
new
viral
ifn
antagonist
almost
doubl
underpin
speed
field
develop
tabl
compil
current
literatur
includ
viral
protein
act
ifn
antagonist
whether
experiment
proof
come
express
studi
infect
mutant
virus
lack
put
ifn
antagonist
latter
issu
great
import
sinc
singl
gene
express
may
result
aberr
express
local
interact
viral
protein
compar
viru
infect
cell
henc
protein
identifi
overexpress
may
retain
phenotyp
context
infect
figur
summar
step
ifn
system
differ
virus
interfer
although
lay
beyond
scope
review
discuss
antagonist
detail
one
discuss
exemplifi
differ
strategi
use
virus
subvert
ifn
respons
major
ifn
antagonist
exert
action
one
four
differ
strategi
gener
inhibit
cellular
gene
express
ii
sequestr
molecul
ifn
circuit
iii
proteolyt
cleavag
innat
immun
compon
iv
target
compon
proteasom
degrad
tabl
gener
block
gene
express
featur
seen
variou
rna
virus
fluav
vsv
pv
rvfv
bunv
seem
provid
effici
mean
prevent
synthesi
ifn
also
addit
antivir
molecul
detriment
viru
replic
wherea
host
shutoff
larg
dsdna
virus
herp
simplex
viru
partli
relat
necess
tempor
regul
express
gene
rna
virus
seem
mainli
block
viral
gene
express
circumv
express
antivir
protein
virus
interfer
three
step
ifn
system
evid
inhibit
earli
step
cascad
implicitli
inhibit
induct
downstream
molecul
amplif
ifn
signal
viral
ifn
antagonist
exclus
produc
infect
cell
impli
surround
uninfect
cell
still
stimul
establish
antivir
state
system
ifn
reason
larg
dsdna
virus
express
solubl
ifnbind
protein
compet
cellular
ifn
receptor
ligand
tabl
viroceptor
neutral
secret
ifn
therebi
prevent
autocrin
amplif
possibl
strategi
enabl
virus
persist
host
longer
time
dissemin
hardtoinfect
cell
fact
nearli
virus
ifn
antagonist
identifi
interfer
multipl
step
ifn
respons
figur
exemplifi
necess
virus
success
circumv
ifn
respons
moreov
approxim
one
third
virus
encod
antagonist
interfer
one
step
ifn
respons
system
figur
underpin
pleiotrop
natur
viral
protein
sever
viral
ifn
antagonist
conserv
within
distinct
rna
viru
famili
wherea
dsdna
virus
use
common
protein
antagon
ifn
respons
tabl
may
partli
explain
bia
data
avail
differ
viru
famili
contrari
may
explain
stricter
genom
restrict
rna
virus
evolutionari
pressur
encod
maximum
function
rel
limit
genom
capac
drive
high
degre
multifunction
rna
viru
protein
genom
size
restrict
make
deriv
new
larg
gene
encod
ifn
antagonist
host
case
larg
dsdna
virus
eg
solubl
ifn
receptor
decoy
consider
restrict
variabl
accessori
protein
found
rna
virus
may
explain
relat
rna
virus
use
viral
protein
antagon
ifn
system
wherea
conserv
limit
larg
dsdna
virus
tabl
nine
common
rna
viru
antagonist
stand
tabl
convincingli
demonstr
protein
involv
prevent
nuclear
transloc
bind
nuclear
transport
protein
karyopherin
contribut
pathogen
addit
coronavirida
three
genera
within
flavivirida
famili
also
share
common
antagonist
within
genu
pestivirus
bvdv
csfv
npro
protein
target
proteasom
degrad
moreov
ern
protein
report
sequest
dsrna
contrast
flavivirus
modul
jakstat
signal
albeit
slightli
differ
mechan
hepacivirus
hcv
gbvb
cleav
mav
main
proteas
therebi
render
unabl
confer
signal
rigi
use
similar
strategi
enterovirus
commonli
cleav
mav
innat
immun
molecul
main
proteas
contrast
nonenterovirus
within
picornavirida
famili
express
l
protein
target
nfkb
despit
sophist
mechan
use
virus
inhibit
ifn
respons
hallmark
viru
infect
induct
ifn
infect
host
thu
viral
ifn
antagon
complet
probabl
underscor
need
virus
econom
resourc
assur
optim
replic
transmiss
moreov
host
also
select
pressur
overcom
viral
antagon
ifn
exemplifi
exampl
posit
select
key
compon
ifn
system
target
virus
pkr
appear
rapidli
evolv
mammalian
host
escap
antagon
poxviru
pkr
inhibitor
inhibitori
strategi
seem
higher
preval
certain
viru
class
exampl
nearli
virus
ssrna
genom
interfer
sensori
molecul
wherea
much
less
virus
genom
figur
contrast
ssrna
dsdna
virus
prefer
target
irf
mean
interfer
ifn
induct
final
ssrna
virus
target
ifn
signal
step
lesser
extent
virus
figur
notabl
except
member
flavivirida
although
pattern
may
explain
select
bia
studi
virus
may
also
indic
differ
viru
famili
may
util
certain
domin
strategi
antagon
ifn
respons
strategi
necessarili
provid
broadest
possibl
antagon
eg
block
gener
gene
express
may
strongli
influenc
type
infect
eg
acut
chronic
persist
vectorhost
speci
infect
cell
type
recent
sever
virus
report
partli
circumv
ifn
circuit
activ
upregul
cellular
inhibitor
jakstat
pathway
pkr
cellular
pkr
inhibitor
ipk
activ
fluav
tmv
tev
infect
contribut
neg
regul
pkr
direct
proteinprotein
interact
contrast
fluav
rsv
hcv
hsv
induc
express
neg
regul
jakstat
pathway
remain
unclear
inhibit
cellular
compon
gener
cellular
stressinduc
neg
feedback
loop
activ
viru
infect
resolv
finetun
ifn
respons
hostmicrob
interact
virus
virus
specif
modul
cell
use
protein
better
understand
molecular
mechan
ifn
antagonist
influenc
viral
replic
pathogenesi
indic
ifn
antagonist
knockout
virus
promis
candid
live
viru
vaccin
sever
group
shown
virus
lack
fulli
function
ifn
antagonist
rapidli
clear
vivo
result
potent
ifn
respons
replic
compet
natur
ensur
establish
longlast
immun
memori
moreov
virus
grown
larg
quantiti
ifndefici
host
potenti
vaccin
stock
far
influenza
ab
viru
delet
mutant
test
mice
show
could
protect
challeng
wildtyp
viru
also
recent
evid
studi
sarscov
jev
e
rsv
mutant
virus
suggest
virus
likewis
repres
good
vaccin
candid
gener
attenu
virus
aim
achiev
optim
balanc
minim
clinic
symptom
maximum
replic
nasal
mucosa
mucos
immun
especi
effect
respiratori
virus
influenza
virus
rsv
coronavirus
vaccin
costeffect
method
prevent
viru
infect
diseas
howev
certain
circumst
immun
compromis
patient
antivir
drug
crucial
treat
acut
lifethreaten
case
virus
lack
ifn
antagonist
sever
attenu
make
viral
ifn
antagonist
protein
prime
drug
target
screen
larg
librari
smallmolecul
inhibitor
alreadi
identifi
potenti
new
lead
compound
variou
clinic
relev
virus
sever
studi
tissu
cultur
indic
viabl
strategi
develop
antivir
drug
although
potenti
compound
inhibit
viru
replic
vivo
remain
unclear
recent
surg
public
viral
ifn
antagonist
underpin
necess
everi
viru
interfer
innat
immun
system
provid
potenti
target
antivir
drug
ration
vaccin
design
howev
limit
number
describ
antagonist
extens
valid
anim
model
infect
studi
recombin
virus
lack
ifn
antagonist
nevertheless
recent
studi
recombin
ebola
viru
sarscov
mutant
lack
ifn
antagonist
initi
identifi
express
studi
prove
potenti
approach
depth
character
ifn
antagonist
vivo
crucial
develop
new
vaccin
candid
identif
lead
compound
diminish
ifn
antagonist
function
viral
infect
sinc
variou
ifn
antagonist
target
multipl
protein
drug
viral
factor
may
prove
work
doubl
edg
sword
benefit
drug
would
inhibit
two
distinct
mode
antagon
also
resist
viru
mutant
less
like
aris
sinc
would
facilit
function
particular
viral
antagonist
also
direct
role
viru
replic
would
good
drug
target
obtain
crystal
structur
viral
antagonist
complex
differ
viral
cellular
ligand
crucial
ration
design
drug
